Week In Review: Alphamab Oncology Plans $350 Million Hong Kong IPO
December 07, 2019 at 17:15 PM EST
Alphamab Oncology, a company developing eight bispecifics for oncology, plans to stage an IPO before the end of the year on the Hong Kong Exchange that could raise up to $350 million.